News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Rachel A. Freedman

Articles by Rachel A. Freedman

107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases

BySarah Sammons,Rachel A. Freedman,Adam M. Brufsky,Ahmad Awada,Sara A. Hurvitz, MD,Nancy U. Lin, MD,Cristina Saura,Sheri Leung,Bethann S Hromatka

April 9th 2025

Latest Updated Articles

107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases
April 9th 2025

Trending on CancerNetwork

Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology

FDA Approves Afami-cel in Metastatic Synovial Sarcoma

EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC

Exploring The Future of Artificial Intelligence and Thoracic Oncology

Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC